Soligenix Inc (SNGX)

[bbking2003]

Read what Soligenix’s CEO, Dr.Schaber, said:

“With approximately $7.4 million of cash, we can continue to evaluate other clinical applications for oral BDP in the areas of radiation enteritis, radiation injury, and Crohn’s disease. With continued additional funding under our $9.4 million NIH grant, we can also continue to pursue development of our heat stabilization technology for subunit vaccines including application to RiVax, our vaccine against ricin toxin. Additionally, we will be instituting cost containment measures as we evaluate our strategic options, including whether to further pursue the applications of orBec in the GVHD treatment and prevention space in light of the results of the recent Phase 3 clinical trial.”

Did you see the light at the end of tunnel? Some investors did and so OTC traders, who are always starving for markets with bounce potentials.